◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items
Immuno-Biological Laboratories Co.,Ltd. — Financial Statements
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line ItemFY 2025Mar 31, 2025FY 2024Mar 31, 2024FY 2023Mar 31, 2023FY 2022Mar 31, 2022FY 2021Mar 31, 2021
+Revenue 969.5M 816.7M 794.6M 647.6M 602.7M
Revenue Growth % 18.7% 2.8% 22.7% 7.4% --
+Operating Income 209.3M 104.3M 58.4M -122.2M -241.0M
Operating Margin % 21.6% 12.8% 7.3% -18.9% -40.0%
Non Operating Income 4.9M 22.3M 19.2M 32.3M 22.2M
Non Operating Expenses 4.4M 1.2M 227.1M 153.5M 91.7M
Ordinary Income 209.9M 125.4M -149.5M -243.5M -310.5M
Income Before Taxes 209.9M 124.6M -280.6M -250.1M -310.6M
Income Taxes -39.2M -62.0M 9.1M 8.6M 8.2M
+Net Income 249.0M 186.7M -289.7M -258.8M -318.8M
Net Margin % 25.7% 22.9% -36.5% -40.0% -52.9%
Eps 26.74 20.05 -31.10 -27.78 -34.23
Depreciation Amortization 15.4M 2.3M -- -- --
Line ItemFY 2025Mar 31, 2025FY 2024Mar 31, 2024FY 2023Mar 31, 2023FY 2022Mar 31, 2022FY 2021Mar 31, 2021
Cash And Deposits 825.7M 734.1M 614.2M 508.4M 604.2M
Current Assets 1.4B 1.3B 1.2B 1.1B 1.1B
Property Plant Equipment 191.1M 135.8M 119.3M 120.1M 127.1M
Noncurrent Assets 455.1M 356.5M 269.0M 575.6M 713.1M
Total Assets 1.8B 1.6B 1.4B 1.7B 1.8B
Current Liabilities 281.3M 257.8M 252.0M 228.1M 145.0M
Total Liabilities 331.0M 353.3M 355.7M 337.0M 208.8M
Retained Earnings 425.9M 176.9M -4.0B -3.7B -3.5B
Total Equity 1.5B 1.3B 1.1B 1.4B 1.6B
Equity Ratio 0.82 0.78 0.75 0.80 0.89
Book Value Per Share 162.60 135.85 115.81 146.92 174.70
Num Employees 58.00 57.00 60.00 63.00 65.00
Roe 0.18 0.16 -- -- --
Line ItemFY 2025Mar 31, 2025FY 2024Mar 31, 2024FY 2023Mar 31, 2023FY 2022Mar 31, 2022FY 2021Mar 31, 2021
Operating Cash Flow 183.5M 133.8M 26.5M -93.2M -194.1M
Investing Cash Flow -53.7M -24.5M 30.0M -155.6M -17.2M
Financing Cash Flow -31.8M 991,000 991,000 144.0M -216.0M
NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...